Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt No Debt
NAS:AVRO's Cash-to-Debt is ranked higher than
58% of the 1078 Companies
in the Global Biotechnology industry.

( Industry Median: 64.02 vs. NAS:AVRO: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:AVRO' s Cash-to-Debt Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Interest Coverage No Debt
NAS:AVRO's Interest Coverage is ranked lower than
54% of the 500 Companies
in the Global Biotechnology industry.

( Industry Median: 10000.00 vs. NAS:AVRO: No Debt )
Ranked among companies with meaningful Interest Coverage only.
NAS:AVRO' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Altman Z-Score: 54.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
ROE % -59.84
NAS:AVRO's ROE % is ranked lower than
99.99% of the 989 Companies
in the Global Biotechnology industry.

( Industry Median: -42.82 vs. NAS:AVRO: -59.84 )
Ranked among companies with meaningful ROE % only.
NAS:AVRO' s ROE % Range Over the Past 10 Years
Min: -59.84  Med: 0 Max: 0
Current: -59.84
-59.84
0
ROA % -51.37
NAS:AVRO's ROA % is ranked lower than
97% of the 1084 Companies
in the Global Biotechnology industry.

( Industry Median: -34.77 vs. NAS:AVRO: -51.37 )
Ranked among companies with meaningful ROA % only.
NAS:AVRO' s ROA % Range Over the Past 10 Years
Min: -300.24  Med: -193.31 Max: -51.37
Current: -51.37
-300.24
-51.37
ROC (Joel Greenblatt) % -3484.37
NAS:AVRO's ROC (Joel Greenblatt) % is ranked lower than
85% of the 1036 Companies
in the Global Biotechnology industry.

( Industry Median: -521.46 vs. NAS:AVRO: -3484.37 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:AVRO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -10536.39  Med: -10536.39 Max: -3484.37
Current: -3484.37
-10536.39
-3484.37
GuruFocus has detected 1 Warning Sign with Avrobio Inc NAS:AVRO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:AVRO's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

AVRO Guru Trades in

AVRO Guru Trades in

Q2 2018

AVRO Guru Trades in Q2 2018

Paul Tudor Jones 7,500 sh (New)
Leon Cooperman 50,000 sh (New)
» More
Q3 2018

AVRO Guru Trades in Q3 2018

Leon Cooperman Sold Out
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with NAS:AVRO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Avrobio Inc does not have enough historical financial data to display Peter Lynch Chart.

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325414    SIC: 2836
Compare: » details
Headquarter Location:


Ratios

vs
industry
vs
history
PB Ratio 4.21
AVRO's PB Ratio is ranked lower than
99.99% of the 962 Companies
in the Global Biotechnology industry.

( Industry Median: 4.10 vs. AVRO: 4.21 )
Ranked among companies with meaningful PB Ratio only.
AVRO' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 12.85
Current: 4.21
0
12.85
EV-to-EBIT -12.00
AVRO's EV-to-EBIT is ranked lower than
99.99% of the 261 Companies
in the Global Biotechnology industry.

( Industry Median: 22.17 vs. AVRO: -12.00 )
Ranked among companies with meaningful EV-to-EBIT only.
AVRO' s EV-to-EBIT Range Over the Past 10 Years
Min: -69.25  Med: 0 Max: 0
Current: -12
-69.25
0
EV-to-EBITDA -12.09
AVRO's EV-to-EBITDA is ranked lower than
99.99% of the 281 Companies
in the Global Biotechnology industry.

( Industry Median: 18.08 vs. AVRO: -12.09 )
Ranked among companies with meaningful EV-to-EBITDA only.
AVRO' s EV-to-EBITDA Range Over the Past 10 Years
Min: -69.44  Med: 0 Max: 0
Current: -12.09
-69.44
0
Current Ratio 25.81
AVRO's Current Ratio is ranked lower than
70% of the 1074 Companies
in the Global Biotechnology industry.

( Industry Median: 4.46 vs. AVRO: 25.81 )
Ranked among companies with meaningful Current Ratio only.
AVRO' s Current Ratio Range Over the Past 10 Years
Min: 2.4  Med: 11.56 Max: 25.81
Current: 25.81
2.4
25.81
Quick Ratio 25.81
AVRO's Quick Ratio is ranked lower than
66% of the 1074 Companies
in the Global Biotechnology industry.

( Industry Median: 4.18 vs. AVRO: 25.81 )
Ranked among companies with meaningful Quick Ratio only.
AVRO' s Quick Ratio Range Over the Past 10 Years
Min: 2.4  Med: 11.56 Max: 25.81
Current: 25.81
2.4
25.81

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 4.38
AVRO's Price-to-Net-Cash is ranked lower than
99.99% of the 613 Companies
in the Global Biotechnology industry.

( Industry Median: 7.29 vs. AVRO: 4.38 )
Ranked among companies with meaningful Price-to-Net-Cash only.
AVRO' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.24  Med: 6.94 Max: 9.31
Current: 4.38
4.24
9.31
Price-to-Net-Current-Asset-Value 4.32
AVRO's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 745 Companies
in the Global Biotechnology industry.

( Industry Median: 6.45 vs. AVRO: 4.32 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
AVRO' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.19  Med: 6.87 Max: 9.2
Current: 4.32
4.19
9.2
Price-to-Tangible-Book 4.22
AVRO's Price-to-Tangible-Book is ranked lower than
99.99% of the 894 Companies
in the Global Biotechnology industry.

( Industry Median: 5.32 vs. AVRO: 4.22 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AVRO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.09  Med: 6.73 Max: 8.99
Current: 4.22
4.09
8.99
Earnings Yield (Greenblatt) % -8.33
AVRO's Earnings Yield (Greenblatt) % is ranked higher than
69% of the 1081 Companies
in the Global Biotechnology industry.

( Industry Median: -7.73 vs. AVRO: -8.33 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AVRO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -9.62  Med: 0 Max: 0
Current: -8.33
-9.62
0

More Statistics

EPS (TTM) $ -6.67
52-Week Range $20.30 - 53.70
Shares Outstanding (Mil)23.96

Analyst Estimate

Dec18 Dec19 Dec20 Dec21
Revenue (Mil $)
EBIT (Mil $) -43 -70 -81 -89
EBITDA (Mil $) -43 -70 -81 -88
EPS ($) -2.96 -2.93 -3.34 -3.61
EPS without NRI ($) -2.96 -2.93 -3.34 -3.61
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}